Akụkọ

Na Maachị 12^th 2022, nkeNMPA (SFDA) wepụtara ọkwa na-akwado mgbanwe ngwa maka nnwale onwe nke ngwaahịa antigen COVID-19 nke Nanjing Vazyme Biotech nyere.Ụlọ ọrụ, Ltd, Beijing Jinwofu Bioengineering TechnologyỤlọ ọrụ, Ltd, Shenzhen Huada Yinyuan Pharmaceutical Technology Co., Ltd, Ụgwọ nke ụlọ ọrụ Guangzhou Wondfo Biotech Co., Ltd naBỤgwọ nke ụlọ ọrụ eijing Savant Biotechnology Co.,Ltd(Huaketai). Ewepụtala ngwaahịa COVID-19 antigen ise iji nwalee onwe ya.

Na Machị 11th 2022, NHC kwuwapụtala na, iji kwalite atụmatụ nnwale Coronavirus novel wee gboo mkpa mgbochi na njikwa COVID-19, otu ndị otu nke njikọ mgbochi na njikwa njikwa nke steeti steeti kpebiri ịgbakwunye. Nnwale antigen na nnwale nucleic acid wee mee “Protocol Application for Novel Coronavirus Antigen Detection (Nnwale)”
Protocol ahụ na-akọwapụta ọnụọgụgụ ọdabara maka nnwale antigen:
Nke mbụ, ndị na-eleta ụlọ ọrụ ahụike nke mbụ ma nwee mgbaàmà dịka akụkụ iku ume na ahụ ọkụ n'ime ụbọchị 5 nke mmalite nke mgbaàmà;
Nke abụọ, ndị ọrụ nleba anya kwarantaini, gụnyere nleba anya iche iche ụlọ, kọntaktị nso na nso nso a, nleba anya iche iche, mpaghara njide na ndị ọrụ mpaghara;
Nke atọ bụ ndị bi n'ime obodo nwere mkpa maka nchọpụta onwe onye antigen.

NDỤMỌDỤ: Nchọpụta Antigen bụ ihe mgbakwunye dị mkpa nke nchọpụta nucleic acid, mana nsonaazụ nke nchọpụta onwe onye antigen enweghị ike iji mee ihe ndabere maka nyocha nke ọrịa.